Related Experiment Videos
TNF alpha is important in human lung allergic reactions
T B Casale1, J J Costa, S J Galli
1Department of Internal Medicine, VA Medical Center, Iowa City, Iowa, USA.
Summary
Tumor necrosis factor alpha (TNF alpha) is released during allergic respiratory reactions and drives granulocyte migration. This study found TNF alpha is produced in sufficient amounts to impact allergic responses in human lungs.
Area of Science:
- Immunology
- Respiratory Medicine
- Cell Biology
Background:
- Tumor necrosis factor alpha (TNF alpha) is a cytokine implicated in allergic respiratory reactions.
- Mast cells and eosinophils release TNF alpha, promoting mediator release and granulocyte migration.
Purpose of the Study:
- To investigate TNF alpha production in IgE-mediated allergic responses in human lungs.
- To determine if TNF alpha levels are sufficient to induce granulocyte migration.
- To identify cells expressing TNF alpha mRNA during these responses.
Main Methods:
- Human lung fragments were treated with anti-IgE to induce an IgE-mediated response.
- Histamine release and chemotactic activity were measured.
- TNF alpha levels and mRNA expression were assessed using ELISA and in situ hybridization.
- The effect of anti-TNF alpha antibody on neutrophil migration was evaluated.
Main Results:
- Anti-IgE treatment significantly increased histamine release and generated chemotactic activity for neutrophils and eosinophils.
- TNF alpha levels increased significantly post anti-IgE treatment, with measured concentrations inducing neutrophil transendothelial migration.
- Anti-TNF alpha antibody partially inhibited neutrophil chemotactic activity.
- In situ hybridization revealed an increase in TNF alpha mRNA-positive cells, including eosinophils, after anti-IgE stimulation.
Conclusions:
- IgE-mediated responses in human lungs release TNF alpha at biologically significant levels, promoting granulocyte chemotaxis.
- Eosinophils and other cells upregulate TNF alpha mRNA during IgE-mediated allergic reactions.
- TNF alpha is suggested to be a key effector molecule in the pathogenesis of allergic respiratory diseases.